Literature DB >> 18282317

Trajectory of mild cognitive impairment onset.

Diane B Howieson1, Nichole E Carlson, M Milar Moore, Dara Wasserman, Cena D Abendroth, Jessica Payne-Murphy, Jeffrey A Kaye.   

Abstract

The objective was to identify the trajectories of onset of memory and other cognitive loss in persons destined to develop mild cognitive impairment (MCI) or dementia. Healthy, community dwelling, cognitively intact elders (n = 156, mean age at entry = 83 years) were examined annually for an average of greater than 7 years. Those who developed at least two consecutive Clinical Dementia Ratings >or= 0.5 were classified as having MCI. Longitudinal mixed effects models with a change point were used to model the aging process in those with and without an MCI diagnosis during follow-up and to model the rate of change relative to the age of onset of MCI. MCI had a preclinical stage of accelerated cognitive loss that was observed 3 to 4 years before the diagnosis of MCI on tests of verbal memory, animal fluency, and visuospatial constructions. Evidence from memory performance before the change point suggests that a slow decline in memory precedes the period of accelerated decline in the development of MCI. Aging transitions leading to MCI and dementia are characterized by unique linear and nonlinear cognitive changes in several domains that precede the diagnosis of MCI and dementia by at least several years.

Entities:  

Mesh:

Year:  2008        PMID: 18282317     DOI: 10.1017/S1355617708080375

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  64 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

3.  Neurodegenerative basis of age-related cognitive decline.

Authors:  R S Wilson; S E Leurgans; P A Boyle; J A Schneider; D A Bennett
Journal:  Neurology       Date:  2010-09-15       Impact factor: 9.910

4.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

5.  Neuropsychological Markers of Cognitive Decline in Persons With Alzheimer Disease Neuropathology.

Authors:  Jason Hassenstab; Sarah E Monsell; Charles Mock; Catherine M Roe; Nigel J Cairns; John C Morris; Walter Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

6.  Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study.

Authors:  Sarah E Monsell; Hiroko H Dodge; Xiao-Hua Zhou; Yunqi Bu; Lilah M Besser; Charles Mock; Stephen E Hawes; Walter A Kukull; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Apr-Jun       Impact factor: 2.703

7.  Jump, Hop, or Skip: Modeling Practice Effects in Studies of Determinants of Cognitive Change in Older Adults.

Authors:  Alexandre Vivot; Melinda C Power; M Maria Glymour; Elizabeth R Mayeda; Andreana Benitez; Avron Spiro; Jennifer J Manly; Cécile Proust-Lima; Carole Dufouil; Alden L Gross
Journal:  Am J Epidemiol       Date:  2016-01-28       Impact factor: 4.897

8.  The δ latent dementia phenotype in the uniform data set: Cross-validation and extension.

Authors:  Brandon E Gavett; Vanessa Vudy; Mary Jeffrey; Samantha E John; Ashita S Gurnani; Jason W Adams
Journal:  Neuropsychology       Date:  2014-08-25       Impact factor: 3.295

9.  Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; V Shane Pankratz; Teresa J Christianson; Robert J Ivnik; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2013-09-17       Impact factor: 3.535

10.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.